What are the new Covid-19 vaccine platforms?

Rising cases of Covid-19 have unsettled the government. It recently approved two new vaccines. But, what is the difference between these vaccines? What platforms are used to develop them? Find out

So far, about 63% of adult Indians have received both doses of Covid-19 vaccines. And more than 90% have got at least one dose.

India has majorly relied on the viral vector vaccine Covishield for its vaccination drive. Over 88% of the doses given out so far have been of Covishield, the Oxford-AstraZeneca vaccine manufactured locally under license by the Serum Institute of India. Covaxin accounted for just a fraction.

The two new vaccines approved for emergency use last month are Serum Institute of India’s Covovax and Biological E’s Corbevax.

With last month’s approval, the country now has eight vaccines in its kitty. Apart from the four discussed earlier, the remaining…get more details